How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

51 results for

Alcohol Detoxification in Ambulatory Setting

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Alcohol Detoxification in Ambulatory Setting

Alcohol Detoxification in Ambulatory Setting Alcohol Detoxification in Ambulatory Setting Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer (...) Administration 4 Alcohol Detoxification in Ambulatory Setting Alcohol Detoxification in Ambulatory Setting Aka: Alcohol Detoxification in Ambulatory Setting , Outpatient Alcohol Withdrawal Protocol From Related Chapters II. Indications with tolerance and withdrawal risk III. Contraindications Long-term intake of large amounts of Abnormal laboratory findings positive for other substances Acute illness Comorbid illness necessitating inpatient management Serious cardiopulmonary conditions Uncontrolled Acute

2018 FP Notebook

2. Ambulatory Alcohol Detoxification With Remote Monitoring

Collaborator: SoberLink, LLC Information provided by (Responsible Party): Anna Lembke, Stanford University Study Details Study Description Go to Brief Summary: This study is designed to examine the feasibility and impact of the use of remote monitoring devices during an outpatient ambulatory alcohol detoxification treatment for patients with alcohol use disorders. Condition or disease Intervention/treatment Phase Alcohol Use Disorder Device: Remote Monitoring with Ambulatory Detox Not Applicable Detailed (...) Ambulatory Alcohol Detoxification With Remote Monitoring Ambulatory Alcohol Detoxification With Remote Monitoring - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Ambulatory Alcohol Detoxification

2018 Clinical Trials

3. Alcohol Detoxification in Ambulatory Setting

Alcohol Detoxification in Ambulatory Setting Alcohol Detoxification in Ambulatory Setting Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer (...) Administration 4 Alcohol Detoxification in Ambulatory Setting Alcohol Detoxification in Ambulatory Setting Aka: Alcohol Detoxification in Ambulatory Setting , Outpatient Alcohol Withdrawal Protocol From Related Chapters II. Indications with tolerance and withdrawal risk III. Contraindications Long-term intake of large amounts of Abnormal laboratory findings positive for other substances Acute illness Comorbid illness necessitating inpatient management Serious cardiopulmonary conditions Uncontrolled Acute

2015 FP Notebook

4. Pharmacological Treatment of Patients with Alcohol Use Disorder

, whereas assessment of past and current tobacco use were also high but showed opportunity for improve- ment. The typical practices of other psychiatrists and mental health professionals are unknown, but rates of tobacco use screening have been declining among psychiatrists practicing in ambulatory settings (Rogers and Sherman 2014). Data from ambulatory settings (Glass et al. 2016) suggest that many individuals receive screening for alcohol use, but approximately one-third of individuals do not. Rates (...) , and treatment is associated with reductions in the risk of relapse and AUD- associated mortality. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individu- als. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment

2017 American Psychiatric Association

5. Alcohol: Adult Unhealthy Drinking

and Behavioral Health can assist in assessments/engagement. • Ambulatory treatment/management of alcohol withdrawal. • Medications for managing alcohol craving and alcohol use disorder. In Behavioral Health • Mental health care: individual and group psychotherapy, psychiatric care and psychological testing. • Chemical dependency care (through a contracted network of providers): assessment and evaluation, chemical dependency counseling, and residential treatment. • Inpatient detoxification (through (...) for withdrawal treatment There is insufficient evidence from published studies to determine the optimal setting for alcohol detoxification. However, there is a consensus that patients with risk factors for complicated withdrawal

2016 Kaiser Permanente Clinical Guidelines

6. Alcohol toolkit

10 2.9 Ambulatory Care Units (ACUs) 10 2.10 Re-attenders 11 2.11 The Paediatric Population including Adolescents 11 2.12 Dual Diagnosis 11 2.13 The Elderly population 11 2.14 Training, competencies and CPD for doctors 12 Appendix 1: Paddington Alcohol Test (2009) 16 Appendix 3: AUDIT-C 20 Appendix 4: Alcohol Withdrawal Management and CIWA Scale 22 Appendix 5: Improving the Detection of Alcohol - Misuse Questionnaire 26 Appendix 6: Job Descriptions for an Alcohol Nurse Specialist 28 The Royal (...) . AUDIT-C This is now more commonly being used in the Emergency Department Setting and is a shortened version (only 3 questions) of the AUDIT tool. The full AUDIT tool is the best evaluated alcohol-screening tool available and was developed by the WHO (2). It focuses on quickly identifying escalating and higher risk drinking as well as dependent drinking. Of particular benefit in the ED setting, the AUDIT-C identifies those who are drinking at increasing/higher risk levels before their drinking

2015 Royal College of Emergency Medicine

7. What is the current evidence for the efficacy of drug consumption rooms?

to create a broad overview of the efficacy of such facilities and will be referred to as 'drug consumption rooms' throughout for clarity. The services provide users with sterile injecting or inhalation equipment and access or referral to health and social care services. DCRs have been implemented in many settings with locations across Western Europe, Australia and North America (1, 3). The overarching aims of implementing DCRs are: • To create a safer environment for PWUD and reduced the amount of high (...) and the facilities' limited coverage of the target population (18, 19), though one model has estimated that Insite may prevent 5-6 infections per year (20). Prevention of hepatitis C in DCR settings has not been extensively explored, however a 2018 questionnaire sent to currently operating DCRs aimed to determine the range and scope of prevention and treatment options in these services. Estimated prevalence rates of hepatitis C were 60% among clients. Of the 49 DCR services that responded, 65% offered hepatitis

2020 Public Health England - Evidence Briefings

8. Managing opioid use disorder in primary care: PEER simplified guideline

creating recommen- dations on their use. 22 Management of comorbid conditions in patients with OUD Management of comorbidities in patients taking OAT can be challenging. Unfortunately, randomized con- trolled evidence in this area is severely lacking. With regard to the management of acute pain in patients taking OAT, 1 RCT reported morphine was superior to meperidine in an emergency setting. 22 This is not always applicable in an ambulatory setting, and nonopioid options were not explored. Similarly (...) Eli Orrantia MD MSc CCFP FCFP Kim Reich RSW Nick Wong MD CCFP(AM) FCFP Nicolas Dugré PharmD MSc Adrienne J. Lindblad ACPR PharmD Abstract Objective To use the best available evidence and principles of shared, informed decision making to develop a clinical practice guideline for a simplified approach to managing opioid use disorder (OUD) in primary care. Methods Eleven health care and allied health professionals representing various practice settings, professions, and locations created a list

2019 CPG Infobase

9. Evidence Brief - Barriers and Facilitators to Use of Medications for Opioid Use Disorder

: · Develop clinical policies informed by evidence; · Implement effective services to improve patient outcomes and to support VA clinical practice guidelines and performance measures; and · Set the direction for future research to address gaps in clinical knowledge. The program is comprised of four ESP Centers across the US and a Coordinating Center located in Portland, Oregon. Center Directors are VA clinicians and recognized leaders in the field of evidence synthesis with close ties to the AHRQ Evidence (...) for OUD? 12 Patient-identified Barriers to OUD Medication Use 12 Patient-identified Facilitators to Use of OUD Medications 14 Provider-Identified Barriers to Prescribing OUD Medications 16 Provider-identified Facilitators to OUD Medication Prescribing 19 Systems-level Barriers and Facilitators to OUD Medication Use 20 Key Question 2: Do these barriers and facilitators vary by patient characteristics, provider characteristics, or setting? 21 Patient Characteristics 21 Provider Characteristics

2019 Veterans Affairs Evidence-based Synthesis Program Reports

10. Treatment of Patients with Schizophrenia

conditions including individuals being treated using integrated collaborative care models or inpatient or outpatient medical settings. Although treatment-related costs are often barriers to receiving treatment and cost-effectiveness considerations are relevant to health care policy, few high-quality studies exist on the cost effectiveness of treatments for schizophrenia. In addition, costs of treatment typically differ by country and geographic region and vary widely with the health system and payment (...) ) and attempts that were aborted or interrupted o Intentional self-injury in which there was no suicide intent Substance Use History • Use of tobacco, alcohol, and other substances (e.g., vaping, marijuana, cocaine, heroin, hallucinogens) and any misuse of prescribed or over-the-counter medications or supplements • Current or recent substance use disorder or change in use of alcohol or other substances Medical History • Whether or not the patient has an ongoing relationship with a primary care health

2020 American Psychiatric Association

11. Opioid Treatments for Chronic Pain

withdrawal during double-blind buprenorphine detoxification. Drug Alcohol Depend. 2015 Jun 01;151:47- 55. doi: 10.1016/j.drugalcdep.2015.02.033. PMID: 25823907. 36. Hernandez I, He M, Brooks MM, et al. Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in Medicare Part D beneficiaries. JAMA Netw Open. 2018 Jun 1;1(2):e180919. doi: 10.1001/jamanetworkopen.2018.0919. PMID: 30646080. 37. Sun EC, Dixit A, Humphreys K, et al. Association between (...) Applicability Applicability was assessed in accordance with the AHRQ's Methods Guide, 35 which is based on the PICOTS (Population, Interventions, Comparators, Outcomes, Timing, Setting) framework. Applicability addresses the extent to which outcomes associated with an intervention are likely to be similar across different patients and settings in clinical practice based on the populations, interventions, comparisons, and outcomes evaluated in the studies. Factors potentially affecting applicability

2020 Effective Health Care Program (AHRQ)

12. Organisation of mental health care for adults in Belgium

of mental health care for adults in Belgium. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). 2019. KCE Reports 318. D/2019/10.273/50 Chapter 07: Smith P, Nicaise P, Neyens I, Hermans K, Thunus S, Walker C, Van Audenhove C, Lorant V. Values and sets of possible organisational solutions: a choice-based stakeholder analysis survey. In: Mistiaen P, Cornelis J, Detollenaere J, Devriese S, Farfan-Portet MI, Ricour C (Editors) Organisation of mental health care for adults (...) 2.3.2 Priorities and plans at the federated level 48 2.4 KEY MESSAGES 50 3 REFERENCES 51 CHAPTER 02 PREVALENCE OF MENTAL HEALTH PROBLEMS 56 AUTHORS: DETOLLENAERE J 1 , GISLE L 2 , MISTIAEN P 1 56 1 INTRODUCTION 56 2 METHODS 56 2.1 PREVALENCE OF MENTAL HEALTH PROBLEMS 56 2.2 MENTAL HEALTH CARE SERVICE USE 57 3 RESULTS 57 3.1 PREVALENCE OF MENTAL HEALTH PROBLEMS 57 3.1.1 Mental distress and mental disorders 57 3.1.2 Emotional problems 58 3.1.3 Problematic alcohol problems 59 3.1.4 Suicidal thoughts

2019 Belgian Health Care Knowledge Centre

13. Withdrawal Management Services in Canada: The National Treatment Indicators Report

, not all provinces and territories were able to provide data, and this report does not include every source of data on WM service events (e.g., private treatment). Please refer to the Methods section for all limitations. Withdrawal Management Services WM services (sometimes referred to as detoxification or detox) offer support and care for the safe management of withdrawal symptoms and medical complications when someone who has a substance use disorder is ceasing to use the substance (Diaper, Law (...) to as detoxification or detox) offer support and care for the safe management of withdrawal symptoms and medical complications of individuals with a substance use disorder who are ceasing to use the substance (Diaper et al., 2014; Mattick & Hall, 1996). The primary objectives of WM services are to support safe completion of the acute phase of withdrawal and to reduce the severity of withdrawal symptoms. Secondary objectives, which can differ among individuals, are to provide a period of rest from substance use

2019 Canadian Centre on Substance Abuse

14. Alcoholism Full Text available with Trip Pro

, some prefer a approach. Detoxification Main article: or 'detox' for alcoholics is an abrupt stop of alcohol drinking coupled with the substitution of drugs, such as , that have similar effects to prevent . Individuals who are only at risk of mild to moderate withdrawal symptoms can be detoxified as outpatients. Individuals at risk of a severe withdrawal syndrome as well as those who have significant or acute comorbid conditions are generally treated as inpatients. Detoxification does not actually (...) ). Diagnostic and statistical manual of mental disorders : DSM-5 (5 ed.). Washington, DC: American Psychiatric Association. pp. 490–97. . ^ . from the original on 3 June 2015 . Retrieved 9 May 2015 . ^ Moonat, S; Pandey, SC (2012). . Alcohol Research : Current Reviews . 34 (4): 495–505. . . ^ Morgan-Lopez, AA; Fals-Stewart, W (May 2006). . Exp Clin Psychopharmacol . 14 (2): 265–73. : . . . ^ Blondell, RD (February 2005). "Ambulatory detoxification of patients with alcohol dependence". Am Fam Physician . 71

2012 Wikipedia

15. Implementing Supervised Injection Services

the recommendations that are applicable to your setting and that can be used to address your organization’s existing needs or gaps. 4. Develop a plan for implementing recommendations, sustaining best practices, and evaluating outcomes. 5. Lobby governments to ensure that legislation and regulation support the implementation of the recommendations (e.g., scope of practice, affordable housing, and health human resources). 6. Advocate for funding to support the implementation of recommendations. Implementation (...) , and research positions in a range of health-care organizations, practice areas, and academic settings. These experts work with people who inject drugs who are receiving services and supports in a wide range of health-care settings (e.g., SIS, community health centres, harm reduction programs, public health, and primary health care) or represent other sectors (such as post-secondary institutions and professional unions). To determine the purpose and scope of this Guideline, the RNAO Best Practice Guideline

2018 Registered Nurses' Association of Ontario

16. Hepatitis C Screening

that patients get the best outcomes from their care. The Department of Health is of the view that supporting evidence-based practice, through the clinical effectiveness framework, is a critical element of the health service to deliver safe and high quality care. The National Clinical Effectiveness Committee (NCEC) is a Ministerial committee set up in 2010 as a key recommendation of the report of the Commission on Patient Safety and Quality Assurance (2008). The establishment of the Commission was prompted (...) by an increasing awareness of patient safety issues in general and high profile health service system failures at home and abroad. The NCEC on behalf of the Department of Health has embarked on a quality assured National Clinical Guideline development process linked to service delivery priorities. Furthermore, implementing National Clinical Guidelines sets a standard nationally, to enable healthcare professionals to deliver safe and effective care and treatment while monitoring their individual, team

2017 National Clinical Guidelines (Ireland)

17. Managing Chronic Non-Terminal Pain in Adults Including Prescribing Controlled Substances

Managing Chronic Non-Terminal Pain in Adults Including Prescribing Controlled Substances 1 Quality Department Guidelines for Clinical Care Ambulatory Chronic Pain Management Guideline Team Team Leads Daniel W Berland, MD General Medicine / Anesthesiology Phillip E Rodgers, MD Family Medicine Team Members Carmen R Green, MD Anesthesiology R Van Harrison, PhD Medical Education Randy S Roth, PhD Physical Medicine & Rehabilitation Consultants Daniel J. Clauw, MD Rheumatology Jennifer A. Meddings (...) , MD General Medicine Ronald A Wasserman, MD Anesthesiology Initial Release March, 2009 Interim/Meaningful Revision November, 2016 Interim Minor Revision January, 2015 June, 2017 Ambulatory Clinical Guidelines Oversight Grant Greenberg, MD, MA, MHSA R. Van Harrison, PhD Literature search service Taubman Health Sciences Library For more information 734-936-9771 © Regents of the University of Michigan These guidelines should not be construed as including all proper methods of care or excluding other

2017 University of Michigan Health System

18. Interventions Targeting Sensory Challenges in Children with Autism Spectrum Disorder - An Update

-011-9089-0. PMID: 21818630.X-1 701. Kohls G, Peltzer J, Schulte-Rüther M, et al. Atypical Brain Responses to Reward Cues in Autism as Revealed by Event-Related Potentials. Journal of Autism & Developmental Disorders. 2011;41(11):1523-33 11p. doi: 10.1007/s10803-011-1177-1. PMID: 104703794. Language: English. Entry Date: 20111109. Revision Date: 20150711. Publication Type: Journal Article.X-1 702. Komoto Y, Hashimoto N, Ikegami Y. [Effects of autism features on alcoholism--especially from (...) .0026077. PMID: 22016815.X-1 755. Miller JS, Gabrielsen T, Villalobos M, et al. The each child study: systematic screening for autism spectrum disorders in a pediatric setting. Pediatrics. 2011 May;127(5):866-71. doi: 10.1542/peds.2010-0136. PMID: 21482605.X-1 756. Mills R, Marchant S. Feature: Intervention in autism: a brief review of the literature. Tizard Learning Disability Review. 2011;16(4):20-35 16p. doi: 10.1108/13595471111172822. PMID: 104687522. Language: English. Entry Date: 20111016

2017 Effective Health Care Program (AHRQ)

19. Management of Opioid Therapy (OT) for Chronic Pain

and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of these guidelines is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. These guidelines are not intended to represent TRICARE policy. Further, inclusion of recommendations for specific testing and/or therapeutic interventions (...) , 2016.[33] The aim of the guideline is to assist primary care providers in offering safe and effective treatment for patients with chronic pain in the outpatient setting (not including active cancer treatment, palliative care, or end-of-life care). It is also aimed at improving communication between providers and patients and decreasing adverse outcomes associated with LOT. The CDC guideline, similar to the VA/DoD OT CPG, covered topics including initiation and continuation of OT, management of OT

2017 VA/DoD Clinical Practice Guidelines

20. The effects of online brief interventions for the prevention and treatment of methamphetamine use

) 35 presented information that included: types of drugs and their effects; problem solving; communication; and harm minimisation. Table 2 included two BIs to treat youth amphetamine use. 26,34 Recruitment. Madras, et al. (2009) 25 recruited adult patients in six USA states in healthcare sites (inpatient, emergency departments, ambulatory, primary and specialty healthcare settings, and community health clinics). Marsden, et al. (2006) 26 recruited youth substance users through youth drug workers (...) 6 References 25 Included articles 26 7 Appendices 28 Appendix Table A: Excluded papers 28 Appendix 1: search strategy for PSYCHINFO 29 Appendix 2: search strategy for Medline 30 Appendix 3: Search strategy for Embase 30 Abbreviations list ANZCTR Australia New Zealand Clinical Trial Registry AREAS Academic Role Expectations and Alcohol Scale BI Brief Intervention BMI Brief Motivational Intervention BRSE Benzodiazepine Refusal Self Efficacy BT Brief Treatment BWSQ Benzodiazepine Withdrawal Symptom

2015 Sax Institute Evidence Check

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>